Low depression frequency is associated with decreased risk of cardiometabolic disease.

Autor: Honigberg MC; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.; Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston Massachusetts., Ye Y; Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut., Dattilo L; Harvard Medical School, Boston Massachusetts., Sarma AA; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston Massachusetts., Scott NS; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston Massachusetts., Smoller JW; Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Harvard Medical School, Boston Massachusetts.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boson, Massachusetts., Zhao H; Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut., Wood MJ; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston Massachusetts., Natarajan P; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.; Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston Massachusetts.
Jazyk: angličtina
Zdroj: Nature cardiovascular research [Nat Cardiovasc Res] 2022 Feb; Vol. 1 (2), pp. 125-131. Date of Electronic Publication: 2022 Feb 14.
DOI: 10.1038/s44161-021-00011-7
Abstrakt: Competing Interests: Competing Interests Statement: P.N. reports grant support from Amgen, Apple, AstraZeneca, Boston Scientific, and Novartis, personal fees from Apple, AstraZeneca, Blackstone Life Sciences, Foresite Labs, Genentech, and Novartis, and spousal employment at Vertex, all unrelated to the present work. All other authors do not report any disclosures.
Databáze: MEDLINE